Theranos and its founder settle U.S. fraud charges: SEC

WASHINGTON (Reuters) – Theranos Inc and its Chief Executive Elizabeth Holmes have agreed to settle fraud charges in a deal that strips her of control over the embattled blood-testing company, among other penalties, U.S. regulators said on Wednesday.

As part of the settlement, the Securities and Exchange Commission said Holmes must also return millions of shares to the privately-held company and cannot serve as an officer or director of a public company for 10 years.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.